Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03775525
Title Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma (GEN602)
Acronym GEN602
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genzada Pharmaceuticals USA, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field